Skip to content

Addressing the burden of coronary heart disease

How to approach screening, risk estimation and management of coronary heart disease in asymptomatic patients An estimated 17.7 million people die of cardiovascular diseases each year representing 31 per cent of all global deaths. Coronary heart disease (CHD) mortality rates worldwide have declined over the past four decades, but CHD remains responsible for about one-third…

Read More

CPD Module- Cardiac Amyloidosis

2 CPD Hours Authors Dr Neasa Starr, Advanced Heart Failure Registrar, and Prof Niall Mahon, Consultant Cardiologist, Mater University Hospital, Dublin Learning objectives of this module: Understand the principal causes (AL amyloidosis and ATTR) and underlying pathophysiology of cardiac amyloidosis Identify patients to screen for cardiac amyloidosis and the subsequent diagnostic process Develop insight into…

Read More

The evolution of catheter ablation

Irish Cardiac Society, 71st Annual Scientific Meeting, 1-3 October 2020 The next presenter in the Saturday morning session was Dr Ed Cronin, Associate Professor at the Lewis Katz School of Medicine at Temple University, Philadelphia, US, who addressed the meeting on the topic ‘Catheter ablation of ventricular arrhythmias’. Dr Cronin provided an overview of the…

Read More

A round-up of some of the most topical research presented at this year’s ESC

Cardiovascular disease is biggest killer globally but cancer overtakes in some countries Cardiovascular disease remains the main cause of death globally, but cancer has overtaken it to become the leading cause of death in some high-income and upper-middle-income countries, according to the late-breaking results from the PURE study, which were presented in a Hot Line…

Read More

Evidence-based approaches to hypertension

A comparison of current European and US guidelines and management principles An estimated 1.13 billion people worldwide have hypertension. It is a major cardiovascular risk factor and a leading risk factor for global deaths. According to the World Health Organisation (WHO), in 2015, one-in-four men and one-in-five women had hypertension and fewer than one-in-five people…

Read More

Managing heart valve disease

As we mark European Heart Valve Disease Awareness Week (www.heartvalveweek.eu) this month (16-22 September), it is important that patients understand that progress and changes in the treatment of heart valve disease make the disease a little less daunting The landscape of cardiac surgery is changing with lightning speed. Cardiac surgery has been the focus of…

Read More

Coming together for cardiac care

Ahead of a landmark conference with the Irish Cardiac Society (ICS) and the Mayo Clinic, US, ICS President Dr Jim Crowley spoke with Pat Kelly about the significance of the event and the overall health of cardiac care in Ireland The conference, titled ‘Cardiology on the Green’, will take place on 4-6 of April in…

Read More

Minimally invasive clipping of the left atrial appendage: Reducing stroke risk in patients with atrial fibrillation

Ms Donna Eaton outlines how device closure of the left atrial appendage has emerged as a safe and effective alternative to anticoagulation for some patients The most serious risk to patients with atrial fibrillation (AF) is thromboembolic stroke. There is a clear relationship between the left atrial appendage (LAA) and stroke in patients with non-valvular…

Read More
Scroll To Top